GAS5 and gastric cancer: This miRNA-mediated tumor-suppressive effect has also been reported for SNHG12 (44), MRPL39 (45), and GAS5 (46) lncRNAs, which modulate signaling pathways in gastric cancer by sponging different miRNAs.